Image Analysis Group

Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform DYNAMIKA, to de-risk clinical drug development through efficient clinical trials and standardized central imaging data review. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates. DYNAMIKA uses AI to power image review, support evaluating more sensitive endpoints, and automate data management processes. With IAG, you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed. For nearly 20 years, the IAG team has helped to reduce investment risk and to accelerate study outcomes in over 700 trials, empowering biotech and pharma sponsors to make data-driven decisions with confidence. Speak to us about imaging in your clinical trials that is focused on:#obesity #oncology #immunology #rheumatology #orthopedics #neurology #radiopharmaceuticals,#bonehealth,#rarediseases